CANCER-ASSOCIATED THROMBOSIS

Clinical trials for CANCER-ASSOCIATED THROMBOSIS explained in plain language.

Never miss a new study

Get alerted when new CANCER-ASSOCIATED THROMBOSIS trials appear

Sign up with your email to follow new studies for CANCER-ASSOCIATED THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Cancer patients face dangerous choice: blood clots vs. bleeding risk

Disease control Recruiting now

This study aims to find the safest way to treat blood clots in cancer patients who also have low platelet counts, which increases their risk of dangerous bleeding. Fifty patients will be randomly assigned to receive either a full dose of blood thinners with platelet transfusions …

Matched conditions: CANCER-ASSOCIATED THROMBOSIS

Phase: PHASE4 • Sponsor: Tzu-Fei Wang • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

CANCER-ASSOCIATED THROMBOSIS

Get alerted when new CANCER-ASSOCIATED THROMBOSIS trials appear

Cancer patients face dangerous choice: blood clots vs. bleeding risk